Qrg Capital Management, Inc. Pacira Bio Sciences, Inc. Transaction History

Qrg Capital Management, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 12, 2024	BUY	$25.5 - $31.51 $219,325 - $271,017	8,601 Added 37.88%	31,309 $896 Million
Q1 2024 May 07, 2024	BUY	$27.7 - $35.48 $186,171 - $238,461	6,721 Added 42.04%	22,708 $664 Million
Q4 2023 Feb 07, 2024	BUY	$26.32 - $34.31 $42,375 - $55,239	1,610 Added 11.2%	15,987 $539 Million
Q3 2023 Nov 13, 2023	BUY	$30.68 - $40.09 $441,086 - $576,373	14,377 New	14,377 $441 Million

263

50.4M

429K

391K

Ticker PCRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,824,200
Market Cap $892M
Description
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...

Get notified when there are updates to the investment portfolio of Qrg Capital Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Qrg Capital Management, Inc. with notifications on news.